Rapid testing for methicillin-resistant Staphylococcus aureus: Implications for antimicrobial stewardship

American Journal of Health-System Pharmacy

Volumn 70, Issue 4, 2013, Pages 335-342

  Geiger, Krystina ^a   Brown, Jack ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM DETECTION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA SEQUENCE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; LABORATORY DIAGNOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAPID TEST; SENSITIVITY AND SPECIFICITY; TURNAROUND TIME;

EID: 84874083185     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110724     Document Type: Article

References (41)

1. Martin C, Ofotokun I, Rapp R et al. Results of an antimicrobial control program at a university hospital. Am J Health-Syst Pharm. 2005; 62:732-8.
2. Carling P, Fung T, Killion A et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003; 24:699-706.
3. Dellit TH, Owens RC, McGowan JE Jr et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44:159-77.
4. Kallen AJ, Mu Y, Bulens S et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA. 2010; 304:641-8.
5. Cosgrove SE, Sakoulas G, Perencevich EN et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003; 36:53-9.
6. Brown J, Paladino JA. Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model. Pharmacoeconomics. 2010; 28:567-75.
7. International vocabulary of metrology - basic and general concepts and associated terms. 3rd ed. Paris: Joint Commission for Guides in Metrology; 2008.
8. hyplex StaphyloResist Plus product information. Giessen, Germany: Amplex BiosyStems GmbH; 2007.
9. Stürenburg E. Rapid detection of methicillin-resistant Staphylococcus aureus directly from clinical samples: methods, effectiveness and cost considerations. Ger Med Sci. 2009; 7:doc06.
10. Brown J, Brown KA, Forrest A. Vancomycin AUC24/MIC in MRSA complicated bacteremia and infective endocarditis patients and its association with attributable mortality during hospitalization. Antimicrob Agents Chemother. 2012; 56:634-8.
11. Moise-Broder PA, Forrest A, Birmingham MC et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004; 43:925-42.
12. Desjardins M, Guibord C, Lalonde B. Evaluation of the IDI-MRSA assay for detection of methicillin-resistant Staphylococcus aureus from nasal and rectal specimens pooled in a selective broth. J Clin Microbiol. 2000; 44:1219-23.
13. Wagenvoort JH, van de Cruijs M, Meuwissen CM. Comparison of an enrichment broth-enhanced commercial PCR procedure versus bacteriological culture for separating non-colonized from suspected or colonized MRSA individuals. Eur J Clin Microbiol Infect Dis. 2007; 26:155-60.
14. GeneOhm MRSA package insert. Franklin Lakes, NJ: BD-Diagnostics; 2011.
15. Boyle-Vavra S, Daum RS. Reliability of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) assay in detecting MRSA isolates with a variety of genotypes from the United States and Taiwan. J Clin Microbiol. 2010; 48:4546-51.
16. Rupp J, Fenner I, Solbach W et al. Be aware of the possibility of false-positive results in single-locus PCR assays for methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2006; 44:2317.
17. Huletsky A, Giroux R, Rossbach V et al. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol. 2004; 42:1875-84.
18. Paule SM, Hacek DM, Kufner B et al. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J Clin Microbiol. 2007; 45:2993-8.
19. Warren DK, Liao RS, Merz LR et al. Detection of methicillin-resistant Staphy-lococcus aureus directly from nasal swab specimens by a real-time PCR assay. J Clin Microbiol. 2004; 42:5578-81.
20. Bisch of LJ, Lapsley L, Fontecchio K et al. Comparison of chromogenic media to BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR for detection of MRSA in nasal swabs. J Clin Microbiol. 2009; 47:2281-3.
21. Snyder JW, Munier GK, Johnson CL. Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from intensive care unit patients. J Clin Microbiol. 2010; 48:1305-9.
22. Grobner S, Dion M, Plante M et al. Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottles. J Clin Microbiol. 2009; 47:1689-94.
23. Stamper PD, Cai M, Howard T et al. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J Clin Microbiol. 2007; 45:2191-6.
24. Cepheid. Xpert MRSA. www.cepheid.com/media/files/brochures/ Xpert%20MRSA%20US%20Brochure-0218-08%20LOR.pdf (accessed 2012 Dec 21).
25. Kelley PG, Grabsch EA, Farrel J et al. Evaluation of the Xpert MRSA/SA blood culture assay for the detection of Staphylococcus aureus including strains with reduced vancomycin susceptibility from blood culture specimens. Diagn Microbiol Infect Dis. 2011; 70:404-7.
26. Wolk DM, Struelens MJ, Pancholi P et al. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol. 2009; 47:823-6.
27. Food and Drug Administration. Cepheid Xpert MRSA/SA blood culture assay for use with the GeneXpert Dx system [medical device recall]. www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm218002.htm (accessed 2012 Nov 5).
28. Food and Drug Administration. Class 3 recall: Cepheid Xpert MRSA/S blood culture. www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=105528 (accessed 2012 Nov 5).
29. Roche Molecular Diagnostics. Light-Cycler SeptiFast Test MGRADE. http://molecular.roche.com/assays/Pages/LightCyclerSeptiFastTestMGRADE.aspx (accessed 2012 Dec 21).
30. Grobner S, Kempf VA. Rapid detection of methicillin-resistant staphylococci by real-time PCR directly from positive blood culture bottles. Eur J Clin Microbiol Infect Dis. 2007; 26:751-4.
31. Lem P, Spiegelman J, Toye B et al. Direct detection of mecA, nuc and 16S rRNA genes in BacT/Alert blood culture bottles. Diagn Microbiol Infect Dis. 2001; 41:165-8.
32. Peterson LR, Liesenfeld O, Woods CW et al. Multicenter evaluation of the LightCycler methicillin-resistant Staphy-lococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs. J Clin Microbiol. 2010; 48:1661-6.
33. Carroll KC. Rapid diagnostics for methicillin-resistant Staphylococcus aureus: current status. Mol Diagn Ther. 2008; 12:15-24.
34. Shrestha NK, Tuohy MJ, Padmanabha RA. Evaluation of the LightCycler Staphy-lococcus MGRADE kits on positive blood culture that contained gram-positive cocci in clusters. J Clin Microbiol. 2005; 43:144-6.
35. KeyPath MRSA/MSSA Blood Culture Test product information. Longmont, CO: MicroPhage, Inc.; 2011.
36. Dreiling N, Smith B, Bush D et al. 5 hour direct identification of MRSA/MSSA bacteremia with a single use kit. Poster presented at International Conference of Antimicrobial Agents and Chemotherapy. Washington, DC; 2008 Oct 15.
37. Ota KV, Turner NN, Roundtree SS et al. Accurate and rapid detection of methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) using the MicroPhage MRSA/MSSA Blood Culture Test in a pediatric population. Poster presented at Annual Meeting of the American Society for Microbiology. New Orleans, LA; 2011 May 23.
38. Smith B, Sportmann B P, Dreiling B et al. General utility of bacteriophage amplification technology for antibiotic susceptibility testing in S. aureus. Poster presented at International Conference on Antimicrobial Agents and Chemotherapy. Washington, DC; 2008 Oct 16.
39. Frye AM, Baker CA, Rustvold DL et al. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J Clin Microbiol. 2012; 50:127-33.
40. Bauer KA, West JE, Balada-Llasat JM et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis. 2010; 51:1074-80.
41. Goff DA. Antimicrobial stewardship: bridging the gap between quality care and cost. Curr Opin Infect Dis. 2011; 24(suppl 1):S11-20.